Hematology:Multiples myeloma — Allogeneic bone marrow transplantation. Treatment abroad
One of the efficient methods for treatment of multiple myeloma is a combination of high-dose chemotherapy with bone marrow transplantation. Extensive experience of such treatment, gained in the major European clinics, testifies to a very good result; up to 60% patients, who have passed the transplantation surgery successfully, show a complete remission.
After the first visit to the clinic and case history collection, the patient undergoes a set of studies, including:
- general clinical examination, i.e. complete blood count and urinalysis, blood chemistry etc.;
- CT or MRI;
- immunological tests help making a differential diagnosis with lymphomas and lymphoid leukemia;
- microscopic examination of the bone marrow punctate.
Selection of a bone marrow donor requires a genetic compatibility analysis. The ideal donor is a sibling of the patient, but in some cases, it is possible to choose a compatible donor who is not the patient’s relative.
Allogeneic Bone Marrow Transplantation
Bone marrow transplant is taken from a donor on the day of surgery or the day before it. The procedure is performed under local anesthesia. The resulting stem cells, after processing, are transfused to the patient intravenously. To monitor the donor cell survival, the patient takes daily blood tests.
The patient is supposed to stay in the clinic full time for to 16 days. Before and immediately after transplantation, the patient is in special conditions caused by an almost complete lack of immune defense. During this period, the services of the qualified nursing staff and strict adherence to the therapeutic regimen are particularly important. The security measures are mitigated gradually.
The cost of required medicines and the actual surgery depends on the clinic and the amount of extra care. After receipt of further recommendations on the monitoring and treatment, the patient is discharged.Hide